[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.236.187.155. Please contact the publisher to request reinstatement.
Views 138
Citations 0
Invited Critique
ONLINE FIRST
May 2012

Impact of Payer Status on Treatment Options for Acute Cholecystitis: Will Health Care Reform Help Us Close the Gap?Comment on “Payer Status and Treatment Paradigm for Acute Cholecystitis”

Author Affiliations

Author Affiliation: Section of Minimally Invasive Surgery, Bariatric Institute, Weston, Florida.

Arch Surg. 2012;147(5):458-459. doi:10.1001/archsurg.2011.1890

The aim of the Greenstein et al1 study was to demonstrate that the Medicaid population has inferior access to undergo a cholecystectomy for acute cholecystitis (AC) when compared with those that have private insurance (PI). Using a Nationwide Inpatient Sample database from 1998 through 2008, the authors reviewed a total of 843 179 patients who had emergent hospitalizations under the diagnosis of AC. Hospitalizations were stratified by primary payer status (Medicaid [n = 219 326] or private [n = 623 853]), and insurance type was analyzed against cholecystectomy in propensity score–matched cohorts. Approximately 200 000 patients were matched in each cohort. The authors arrived at the following results:

×